查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球髓内钉市场-2022-2029
市场调查报告书
商品编码
1140741

全球髓内钉市场-2022-2029

Global Intramedullary Nails Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 170 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场动态

增加老年人口是市场增长的驱动力

据说老年人（65岁以上）受伤的风险很高，即使是很小的力量也很容易损坏。因此，老年人在高衝击或低衝击过程中发生致命骨折的风险增加。在 50 岁以上的女性中，每 10 名女性中就有 4 名会在其一生中经历髋部、椎骨或前臂骨折，她们死于骨折并发症的可能性比死于乳腺癌的可能性更大。 NCBI 在 2020 年发布的一份报告显示，在 2015 年至 2025 年间，西班牙将发生大约 347,564 例髋部骨折。髋部骨折影响超过 85% 的 65 岁以上人群。因此，老年人口的增加将加速市场增长。此外，受伤和运动事故数量的增加、退行性骨病患病率的增加、老年人口的增加等预计将推动市场增长。在不久的将来，创伤固定係统的技术发展预计将增加全球需求。

然而，政府对骨科植入物的严格规定以及与使用髓内钉相关的併发症预计将成为预测期内抑制全球市场增长的主要因素。

地理渗透率

北美地区有望主导全球髓内钉市场

该研究按地区分析了全球市场的髓内钉市场，包括北美、欧洲、亚太地区、南美、中东和非洲。

2021 年，北美将主导全球髓内钉市场。在北美，预计美国在预测期内将出现大幅增长。由于其完善的医疗基础设施和高昂的人均医疗费用，该国拥有巨大的髓内钉市场。此外，预计欧洲在预测期内的价值将出现显着增长。受伤和交通事故数量的增加预计将推动该地区的市场增长。

由于人口众多，主要在印度和中国，预计亚太地区的髓内钉市场将在预测期内快速增长。此外，骨科疾病患病率的增加和经济增长预计将推动亚太地区髓内钉市场的增长。

竞争格局

髓内钉市场对全球市场增长做出贡献的主要参与者包括 B. Braun Melsungen AG、Zimmer Biomet、Smith+Nephew、Johnson &Johnson、Orthopaedic Implant Company、Orthofix Holdings, Inc、Wright Medical Group N.V., Advanced Orthopaedic Solutions、Aysam Ortopedi &Tibbi Cihazlar等。领先的公司正在为髓内钉市场的全球增长采用新型的推出和扩张战略。 2022 年 9 月，Stryker 推出了新的 Gamma4 髋部骨折钉系统。新的 Gamma 系统为外科医生提供了 Stryker 的下一代髓内钉系统。该系统用于治疗稳定性和不稳定性骨折，稳定骨骼，并纠正头部、转子、转子下和股骨干的骨骼畸形。该系统用于许多功能，包括将刮削机率降低 66% 的精密销。 2021 年 9 月，B.Braun Melsungen AG 完成了对 Sterinova Inc. 的收购。

此外，Sterinova 将继续作为 B.Braun 的子公司运营。 2022 年 3 月，B. Braun 收购了专门从事透析浓缩物製备的 Intermedt Medizin & Technik GmbH。此次收购完善了 B.Braun Avitum 部门作为体外血液治疗（透析）系统供应商的广泛产品组合。

COVID-19 的影响。全球髓内钉市场稳步增长

由于非 COVID-19 相关的医疗保健设施以正常速度运行，预计全球对髓内钉的需求增长将在整个 COVID-19 流行期间保持稳定。在当前的 COVID-19 大流行之后，髓内钉市场预计将保持稳定。外科和外科护理被列为具有全球重要性的设施。市场进入者必须解决由 COVID-19 大流行引起的供应链问题并设计适当的解决方案。

全球髓内钉市场报告包括大约 69 个市场数据表、61 个图表和 170 页

内容

第 1 章研究方法与范围

  • 调查方法
  • 调查目的和范围

第 2 章市场定义和概述

第 3 章执行摘要

  • 按类型划分的市场细分
  • 按材料划分的市场细分
  • 按应用划分的市场细分
  • 最终用户的市场细分
  • 按地区划分的市场细分

第 4 章市场动态

  • 市场影响因素
    • 促进因素
      • 老年人口增加
      • 运动伤害和交通事故增加
    • 抑制因素
      • 针对骨科植入物的严格政府法规
    • 影响分析

第 5 章行业分析

  • 波特五力分析
  • 供应链分析
  • 价值链分析
  • PEST 分析
  • 定价分析
  • 监管分析
  • 保险报销分析
  • 未满足的需求
  • 专利趋势

第 6 章 COVID-19 分析

  • COVID-19 的市场分析
    • COVID-19 之前的市场情景
    • COVID-19 的当前市场情景
    • COVID-19 后或未来情景
  • COVID-19 期间的价格动态
  • 供需范围
  • 大流行期间与市场相关的政府举措
  • 製造商的战略举措
  • 总结

第 7 章按类型

  • 长伽马指甲 (LGN)
  • 股骨转子钉 (TFN)
  • Inter troche/sub troche nail (ITST)
  • 其他

第 8 章按材料分类

  • 钛
  • 不銹钢

第 9 章按应用程序

  • 股骨骨折
  • 胫骨骨折
  • 其他

第 10 章最终用户

  • 医院和门诊外科诊所
  • 专科诊所/骨科诊所

第 11 章按地区划分

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他欧洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 其他亚太地区
  • 中东和非洲

第 12 章竞争格局

  • 竞争场景
  • 市场情况/份额分析
  • 併购分析

第 13 章公司简介

  • Stryker
    • 公司概况
    • 产品组合和内容
    • 主要亮点
    • 财务摘要
  • B. Braun Melsungen AG.
  • Zimmer Biomet.
  • Smith+Nephew.
  • Johnson & Johnson.
  • Orthopaedic Implant Company.
  • Orthofix Holdings
  • Wright Medical Group N.V
  • Advanced Orthopaedic Solutions
  • Aysam Ortopedi & Tibbi Cihazlar（*LIST NOT EXHAUSTIVE）

第 14 章重要注意事项

第 15 章 DataM

简介目录
Product Code: DMPH3138

Market Overview

Intramedullary Nails Market was valued at USD YY million in 2021. It is forecasted to reach USD YY million by 2029, growing at a CAGR of 6.5 % during the forecast period (2022-2029).

The intramedullary nail is a metal rod threaded into and through the crack of the medullary cavity of a bone to provide strong protection for the broken bone. For the treatment of femoral shaft fractures, intramedullary nailing is currently considered the gold standard. For most fractures, intramedullary fixation is useful and necessary. Nailing may be applied on proximal and distal extra-articular fractures for more modern nail styles and attention to technique. The growth of the global market for intramedullary nails is projected to rely primarily on the volume of operations undertaken to restore fractured bones. In addition, intramedullary nail fixation has emerged as the gold standard procedure for femoral shaft fractures, a trend predicted during the projected timeframe to fuel the global demand for intramedullary nails.

Market Dynamics: Increasing geriatric population drives market growth

Older adults (65 and up) have a higher risk of injuries and are more vulnerable to damage from even slight force. As a result, older people are at a greater risk of catastrophic fracture through high- or low-impact processes. Four out of every ten women over the age of 50 will undergo a hip, vertebral, or forearm fracture during their lifespan and are more likely to die from fracture complications than breast cancer. A report released by the NCBI in 2020 revealed that between 2015 and 2025, there were about 347,564 hip fractures in Spain. Hip fractures impact more than 85% of people over the age of 65. Thus, the increase in the older population accelerates the market growth. Additionally, the market growth is expected to be fueled due to an increase in injury/sports accidents, an increase in the prevalence of degenerative bone diseases, and an increasing geriatric population. It is expected that technical developments in trauma fixation systems will expand the global demand in the near future.

However, the stringent government regulations for orthopedic implants coupled with the complications associated with the use of intramedullary nails is a key factor expected to curtail the growth of the global market over the forecast period.

Market Segmentation: The trochanteric femoral nail (TFN) segment is projected to be the dominant segment in the market during the forecast period.

Based on the type, the intramedullary nails market has been classified into long gamma nail (LGN), trochanteric femoral nail (TFN), intertroch/subtroch nail (ITST), and others.

Trochanteric femoral nails (TFN) dominated the global market in 2021, whereas the long gamma nail (LGN) is expected to present considerable growth in the near future. It is intended to treat stable and unstable proximal femur fractures, including basal neck fractures, intertrochanteric fractures, and pertrochanteric fractures and combinations. Therefore, the increasing usage of Trochanteric Femoral nails in the treatment is expected to propel segmental growth in the near future.

The global intramedullary nails are segmented on the basis of material, which includes titanium and stainless steel.

Titanium is expected to hold a significant market share in the intramedullary nails market. The added advantages of titanium, such as better biocompatibility and durability, support the segment growth during the forecast period. Moreover, titanium is expected to project a considerable CAGR during the forecast period.

Geographical Penetration: North America region is expected to dominate the global intramedullary nails market

Based on geography, the study analyzes the intramedullary nails market in the global market, including North America, Europe, Asia-Pacific, South America, and the Middle East & Africa.

North America is holding a dominant position in the global intramedullary nails market in 2021. In North America, the U.S. is expected to represent considerable growth during the forecast period. Well-established healthcare infrastructure and high healthcare expenditure per capita in the country result in a huge market for intramedullary nails. Moreover, Europe is expected to represent significant growth in terms of value during the forecast period. The increasing number of injuries and road accidents is expected to propel market growth across the region.

The intramedullary nails market for the Asia Pacific is expected to observe rapid growth over the forecast period, backed by the large population base, especially in India and China. Moreover, an increase in the incidence of orthopedic diseases and economic growth are expected to augment the growth of the Asia Pacific intramedullary nails market.

Competitive Landscape:

The key intramedullary nails market players which are contributing to the growth of the global market include Stryker, B. Braun Melsungen AG., Zimmer Biomet., Smith+Nephew., Johnson & Johnson., Orthopaedic Implant Company., Orthofix Holdings, Inc, Wright Medical Group N.V., Advanced Orthopaedic Solutions, Aysam Ortopedi & Tibbi Cihazlar, among others. The major players are adopting new Type launch and expansion strategies for global growth in the intramedullary nails market. In September 2022, Stryker launched New Gamma4 Hip Fracture Nailing System. This new Gamma System gave surgeons the next generation of Stryker's intramedullary nailing system. This system is indicated for the treatment of stable and unstable fractures as well as for the stabilization of bones and correction of bone deformities in the intracapsular, trochanteric, subtrochanteric and shaft regions of the femur. This system is used in different features like precision pin, which reduce the potential of skiving by 66%. In September 2021, B.Braun Melsungen AG completed the acquisition of Sterinova Inc.

Furthermore, Sterinova continues to operate as a subsidiary of B.Braun. In March 2022, B.Braun acquired Intermedt Medizin & Technik GmbH, a specialist in preparing dialysis concentrates. Through this acquisition, the company completed the extensive product portfolio of its B. Braun Avitum division as a systems provider for extracorporeal blood treatment (dialysis).

COVID-19 Impact: Stable growth of the global intramedullary nails market.

The growth of the global demand for intramedullary nails is projected to stay stable throughout the emergence of the COVID-19 pandemic, as non-COVID-related healthcare facilities continue to run at a regular pace. The market for intramedullary nails is expected to stay stable in the wake of the current COVID-19 pandemic. Surgeries and surgical treatments are listed as critical facilities worldwide. Market participants must solve the supply chain issues raised by the COVID-19 pandemic and design appropriate solutions to resolve them.

The global intramedullary nails market report would provide an access to approximately 69 market data tables, 61 figures and 170 pages

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

  • 3.1. Market Snippet by Type
  • 3.2. Market Snippet by Material
  • 3.3. Market Snippet by Application
  • 3.4. Market Snippet by End User
  • 3.5. Market Snippet by Region

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing Geriatric Population
      • 4.1.1.2. Increasing cases of Sports Injuries and Road Accidents
    • 4.1.2. Restraints:
      • 4.1.2.1. Stringent Government Regulations for Orthopedic Implants
    • 4.1.3. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Value Chain Analysis
  • 5.4. PEST Analysis
  • 5.5. Pricing Analysis
  • 5.6. Regulatory Analysis
  • 5.7. Reimbursement Analysis
  • 5.8. Unmet Needs
  • 5.9. Patent Trends

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Type

  • 7.1. Introduction
  • 7.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type Segment
  • 7.3. Market Attractiveness Index, By Type Segment
    • 7.3.1. Long gamma nail (LGN)*
      • 7.3.1.1. Introduction
      • 7.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    • 7.3.2. Trochanteric femoral nail (TFN)
    • 7.3.3. Intertroch/subtroch nail (ITST)
    • 7.3.4. Others

8. By Material

  • 8.1. Introduction
  • 8.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material Segment
  • 8.3. Market Attractiveness Index, By Material Segment
    • 8.3.1. Titanium*
      • 8.3.1.1. Introduction
      • 8.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    • 8.3.2. Stainless Steel

9. By Application

  • 9.1. Introduction
  • 9.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Segment
  • 9.3. Market Attractiveness Index, By Application Segment
    • 9.3.1. Femoral Fracture*
      • 9.3.1.1. Introduction
      • 9.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    • 9.3.2. Tibial Fracture
    • 9.3.3. Others

10. By End User

  • 10.1. Introduction
  • 10.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User Segment
  • 10.3. Market Attractiveness Index, By End User Segment
    • 10.3.1. Hospitals & Ambulatory Surgical Clinics*
      • 10.3.1.1. Introduction
      • 10.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    • 10.3.2. Specialty/Orthopedic Clinics

11. By Region

  • 11.1. Introduction
  • 11.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
  • 11.3. Market Attractiveness Index, By Region
  • 11.4. North America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. U.S.
      • 11.4.7.2. Canada
      • 11.4.7.3. Mexico
  • 11.5. Europe
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. Germany
      • 11.5.7.2. U.K.
      • 11.5.7.3. France
      • 11.5.7.4. Italy
      • 11.5.7.5. Spain
      • 11.5.7.6. Rest of Europe
  • 11.6. South America
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.6.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.6.7.1. Brazil
      • 11.6.7.2. Argentina
      • 11.6.7.3. Rest of South America
  • 11.7. Asia Pacific
    • 11.7.1. Introduction
    • 11.7.2. Key Region-Specific Dynamics
    • 11.7.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 11.7.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 11.7.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.7.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.7.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.7.7.1. China
      • 11.7.7.2. India
      • 11.7.7.3. Japan
      • 11.7.7.4. Australia
      • 11.7.7.5. Rest of Asia Pacific
  • 11.8. Middle East and Africa
    • 11.8.1. Introduction
    • 11.8.2. Key Region-Specific Dynamics
    • 11.8.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 11.8.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 11.8.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.8.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.8.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

12. Competitive Landscape

  • 12.1. Competitive Scenario
  • 12.2. Market Positioning/Share Analysis
  • 12.3. Mergers and Acquisitions Analysis

13. Company Profiles

  • 13.1. Stryker*
    • 13.1.1. Company Overview
    • 13.1.2. Type Portfolio and Description
    • 13.1.3. Key Highlights
    • 13.1.4. Financial Overview
  • 13.2. B. Braun Melsungen AG.
  • 13.3. Zimmer Biomet.
  • 13.4. Smith+Nephew.
  • 13.5. Johnson & Johnson.
  • 13.6. Orthopaedic Implant Company.
  • 13.7. Orthofix Holdings
  • 13.8. Wright Medical Group N.V
  • 13.9. Advanced Orthopaedic Solutions
  • 13.10. Aysam Ortopedi & Tibbi Cihazlar (*LIST NOT EXHAUSTIVE)

14. Premium Insights

15. DataM Intelligence Analysis

  • 15.1. Appendix
  • 15.2. About Us and Services
  • 15.3. Contact Us